0001209191-14-075098.txt : 20141212
0001209191-14-075098.hdr.sgml : 20141212
20141212184919
ACCESSION NUMBER: 0001209191-14-075098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141210
FILED AS OF DATE: 20141212
DATE AS OF CHANGE: 20141212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shapiro Lucy
CENTRAL INDEX KEY: 0001435944
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 141284684
MAIL ADDRESS:
STREET 1: 10210 GENETIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-10
0
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001435944
Shapiro Lucy
C/O ANACOR PHARMACEUTICALS, INC.
1020 EAST MEADOW CIRCLE
PALO ALTO
CA
94303
1
0
0
0
Common Stock
2014-12-10
4
M
0
3000
7.25
A
39248
D
Common Stock
2014-12-10
4
S
0
3000
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
834
0.60
A
37082
D
Common Stock
2014-12-10
4
S
0
834
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
15000
5.11
A
51248
D
Common Stock
2014-12-10
4
S
0
15000
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
12500
5.20
A
48748
D
Common Stock
2014-12-10
4
S
0
12500
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
7500
14.22
A
43748
D
Common Stock
2014-12-10
4
S
0
7500
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
15000
6.74
A
51248
D
Common Stock
2014-12-10
4
S
0
15000
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
30000
6.92
A
66248
D
Common Stock
2014-12-10
4
S
0
30000
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
1500
7.55
A
37748
D
Common Stock
2014-12-10
4
S
0
1500
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
687
17.14
A
36935
D
Common Stock
2014-12-10
4
S
0
687
35.7864
D
36248
D
Common Stock
2014-12-10
4
M
0
3000
5.54
A
39248
D
Common Stock
2014-12-10
4
S
0
3000
35.7864
D
36248
D
Common Stock
2014-12-11
4
S
0
30801
34.9074
D
5447
D
Common Stock
2014-12-11
4
S
0
120032
34.923
D
72384
I
MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Common Stock
2014-12-12
4
S
0
44384
34.4465
D
28000
I
MCADAMS-SHAPIRO FAMILY TRUST DTD MAY 24, 1999
Common Stock
2014-12-12
4
S
0
5447
34.48
D
0
D
Stock Option (right to buy)
7.25
2014-12-10
4
M
0
3000
7.25
D
2018-01-25
Commmon Stock
3000
0
D
Stock Option (right to buy)
0.60
2014-12-10
4
M
0
834
0.60
D
2015-10-26
Common Stock
834
0
D
Stock Option (right to buy)
5.11
2014-12-10
4
M
0
15000
5.11
D
2023-06-06
Common Stock
15000
0
D
Stock Option (right to buy)
5.20
2014-12-10
4
M
0
12500
5.20
D
2022-05-30
Common Stock
12500
0
D
Stock Option (right to buy)
14.22
2014-12-10
4
M
0
7500
14.22
D
2024-05-29
Common Stock
7500
7500
D
Stock Option (right to buy)
6.74
2014-12-10
4
M
0
15000
6.74
D
2021-05-25
Common Stock
15000
0
D
Stock Option (right to buy)
6.92
2014-12-10
4
M
0
30000
6.92
D
2021-03-31
Common Stock
30000
0
D
Stock Option (right to buy)
7.55
2014-12-10
4
M
0
1500
7.55
D
2020-08-20
Common Stock
1500
0
D
Stock Option (right to buy)
17.14
2014-12-10
4
M
0
687
17.14
D
2024-02-07
Common Stock
687
813
D
Stock Option (right to buy)
5.54
2014-12-10
4
M
0
3000
5.54
D
2022-01-12
Common Stock
3000
0
D
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $35.51 to $36.44, inclusive.
The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $34.68 to $35.66, inclusive.
This option is fully vested and exercisable.
1/12th of the shares subject to the option shall vest and become exercisable in a series of twelve equal monthly installments measured from May 29, 2014.
1/24th of the shares subject to the option shall vest and become exercisable on a monthly basis over the twenty-four months following the vesting commencement date of January 1, 2014.
/s/ Lucy O. Day, as attorney-in-fact
2014-12-12